Independent evaluation of tolerance of therapeutic plasma inactivated by amotosalen-HCl-UVA (Intercept™) over a 5-year period of extensive delivery-Reference-Cited by-同舟云学术

Independent evaluation of tolerance of therapeutic plasma inactivated by amotosalen-HCl-UVA (Intercept™) over a 5-year period of extensive delivery

Published:2015-05-29 Issue:4 Volume:109 Page:414-416
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:Vox Sang

Author:

Bost V.¹,Chavarin P.¹,Boussoulade F.¹,Fabrigli P.¹,Chabre C.¹,Benamara H.¹,Odent-Malaure H.¹,Legrand D.¹,Cognasse F.¹²,Garraud O.²³

Affiliation:

1. Etablissement Français du Sang Auvergne-Loire; Saint-Etienne France

2. GIMAP-EA3064; Université de Lyon; Saint Etienne France

3. Institut National de la Transfusion Sanguine; Paris France

Funder

Etablissement Français du Sang

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/vox.12300/fullpdf

Reference10 articles.

1. Evaluation of the hemostatic potential including thrombin generation of three different therapeutic pathogen-reduced plasmas;Hacquard;Vox Sang,2012

2. Plasma components: properties, differences, and uses;Benjamin;Transfusion,2012

3. Hypersensitivity reactions to blood components: document issued by the allergy committee of the French medicines and healthcare products regulatory agency;Mertes;J Investig Allergol Clin Immunol,2011

4. Plasma treated with methylene blue and light: clinical efficacy and safety profile;Lozano;Transfus Med Rev,2013

5. A regional haemovigilance retrospective study of four types of therapeutic plasma in a ten-year survey period in France;Bost;Vox Sang,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of pathogen-reduction technologies on COVID-19 convalescent plasma potency;Transfusion Clinique et Biologique;2021-05

2. Plasma pooling in combination with amotosalen/ UVA pathogen inactivation to increase standardisation and safety of therapeutic plasma units;Transfusion Medicine;2021-03-08

3. Amotosalen and ultraviolet A light treatment efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in human plasma;Vox Sanguinis;2020-12-05

4. Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic purpura;Transfusion and Apheresis Science;2019-12

5. Cytokines and related molecules, and adverse reactions related to platelet concentrate transfusions;Transfusion Clinique et Biologique;2019-09